Cervicofacial actinomycosis.
Actinomycotic infections are unusual, but the actual incidence is likely to be significantly higher than records indicate. The disease may complicate trauma of many types to the respiratory and digestive tracts, including operative procedures. This possibility should encourage more frequent use of anaerobic cultures in inflammatory diseases, particularly posttraumatic, and should prompt consideration of actinomycosis in the differential diagnosis of infections, especially in the cervicofacial area. We report four cases that demonstrate the variable course of this infection. Treatment is highly successful with appropriate use of antibiotics and surgery. A plea is made to use the least expensive, effective antibiotic in view of the prolonged course of therapy that is necessary to eradicate this infection.
D000038:Abscess / Q000188:drug therapy; D000197:Actinomycosis, Cervicofacial / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery; D000368:Aged; D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000150:complications; D002511:Cephalosporins / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007822:Laryngeal Neoplasms / Q000150:complications; D008297:Male; D008875:Middle Aged; D010306:Parotid Gland / Q000601:surgery; D010400:Penicillin G / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use; D014947:Wounds and Injuries / Q000150:complications
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D000667:Ampicillin; D013752:Tetracycline; D010400:Penicillin G